Intrinsic Value

Keros Therapeutics, Inc. (KROS)

$66.2

+1.54 (+2.38%)

Enterprise Value -
Net Debt -316.70
Equity Value -
Shares Outstanding 29.45
Equity Value Per Share -



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt